Mortality During Treatment for Tuberculosis; a Review of Surveillance Data in a Rural County in Kenya

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Jul 12

PMID 31295277

Citations 15

Authors

Osman A Abdullahi

Moses M Ngari

Deche Sanga

Geoffrey Katana

Annie Willetts

Affiliations

Soon will be listed here.

Abstract

Background: Globally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estimate all-cause mortality rate, identify features associated with mortality and describe trend in mortality rate from treatment initiation.

Method: A 5-year (2012-2016) retrospective analysis of electronic TB surveillance data from Kilifi County, Kenya. The outcome was all-cause mortality within 180 days after starting TB treatment. The risk factors examined were demographic and clinical features at the time of starting anti-TB treatment. We performed survival analysis with time at risk defined from day of starting TB treatment to time of death, lost-to-follow-up or completing treatment. To account for 'lost-to-follow-up' we used competing risk analysis method to examine risk factors for all-cause mortality.

Results: 10,717 patients receiving TB treatment, median (IQR) age 33 (24-45) years were analyzed; 3,163 (30%) were HIV infected. Overall, 585 (5.5%) patients died; mortality rate of 12.2 (95% CI 11.3-13.3) deaths per 100 person-years (PY). Mortality rate increased from 7.8 (95% CI 6.4-9.5) in 2012 to 17.7 (95% CI 14.9-21.1) in 2016 per 100PY (Ptrend<0.0001). 449/585 (77%) of the deaths occurred within the first three months after starting TB treatment. The median time to death (IQR) declined from 87 (40-100) days in 2012 to 46 (18-83) days in 2016 (Ptrend = 0·04). Mortality rate per 100PY was 7.3 (95% CI 6.5-7.8) and 23.1 (95% CI 20.8-25.7) among HIV-uninfected and HIV-infected patients respectively. Age, being a female, extrapulmonary TB, being undernourished, HIV infected and year of diagnosis were significantly associated with mortality.

Conclusions: We found most deaths occurred within three months and an increasing mortality rate during the time under review among patients on TB treatment. Our results therefore warrant further investigation to explore host, disease or health system factors that may explain this trend.

Citing Articles

Mortality and loss to follow-up among Tuberculosis patients on treatment in Meru County, Kenya: a retrospective cohort study.

Ngari M, Mberia J, Kanana E, Sanga D, Ngari M, Nyagah D PLOS Glob Public Health. 2025; 5(3):e0003896.

PMID: 40063632 PMC: 11892847. DOI: 10.1371/journal.pgph.0003896.

Survival analysis shows tuberculosis patients with silicosis experience earlier mortality and need employer-led care models in occupational settings in India.

Rupani M, Soundararajan S Sci Rep. 2024; 14(1):28891.

PMID: 39572724 PMC: 11582735. DOI: 10.1038/s41598-024-80367-5.

Epidemiology and antimicrobial resistance of spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data.

Thomsen J, Abdulrazzaq N, Nyasulu P, Al Hosani F, Habous M, Weber S Front Public Health. 2024; 12:1244353.

PMID: 38947352 PMC: 11211529. DOI: 10.3389/fpubh.2024.1244353.

Mortality among persons with tuberculosis in Zambian hospitals: A retrospective cohort study.

Bwembya J, Kumar R, Musonda V, Chimzizi R, Kasese-Chanda N, Goma L PLOS Glob Public Health. 2024; 4(6):e0003329.

PMID: 38885238 PMC: 11182540. DOI: 10.1371/journal.pgph.0003329.

The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.

Chanda E BMC Infect Dis. 2024; 24(1):364.

PMID: 38556907 PMC: 10983631. DOI: 10.1186/s12879-024-09238-8.

References

Wobudeya E, Sekadde-Kasirye M, Kimuli D, Mugabe F, Lukoye D . Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda. BMC Public Health. 2017; 17(1):963. PMC: 5735639. DOI: 10.1186/s12889-017-4988-y. View

Nagu T, Aboud S, Mwiru R, Matee M, Rao M, Fawzi W . Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy. Int J Infect Dis. 2017; 56:39-44. DOI: 10.1016/j.ijid.2017.01.023. View

Heunis J, Kigozi N, Chikobvu P, Botha S, van Rensburg H . Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health. 2017; 17(1):38. PMC: 5217308. DOI: 10.1186/s12889-016-3972-2. View

. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017; 18(3):261-284. PMC: 5831985. DOI: 10.1016/S1473-3099(17)30703-X. View

Onyango D, Yuen C, Cain K, Ngari F, Masini E, Borgdorff M . Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya. PLoS One. 2017; 12(11):e0188235. PMC: 5690617. DOI: 10.1371/journal.pone.0188235. View

Odone A, Amadasi S, White R, Cohen T, Grant A, Houben R . The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis. PLoS One. 2014; 9(11):e112017. PMC: 4229142. DOI: 10.1371/journal.pone.0112017. View

Menon S, Rossi R, Nshimyumukiza L, Wusiman A, Zdraveska N, Eldin M . Convergence of a diabetes mellitus, protein energy malnutrition, and TB epidemic: the neglected elderly population. BMC Infect Dis. 2016; 16:361. PMC: 4960905. DOI: 10.1186/s12879-016-1718-5. View

Takarinda K, Sandy C, Masuka N, Hazangwe P, Choto R, Mutasa-Apollo T . Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberc Res Treat. 2017; 2017:6232071. PMC: 5352882. DOI: 10.1155/2017/6232071. View

Agbor A, Bigna J, Billong S, Tejiokem M, Ekali G, Plottel C . Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013). PLoS One. 2014; 9(12):e115211. PMC: 4266669. DOI: 10.1371/journal.pone.0115211. View

10.

Cherutich P, Kaiser R, Galbraith J, Williamson J, Shiraishi R, Ngare C . Lack of knowledge of HIV status a major barrier to HIV prevention, care and treatment efforts in Kenya: results from a nationally representative study. PLoS One. 2012; 7(5):e36797. PMC: 3344943. DOI: 10.1371/journal.pone.0036797. View

11.

Odone A, Houben R, White R, Lonnroth K . The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014; 2(9):754-64. DOI: 10.1016/S2213-8587(14)70164-0. View

12.

Verguet S, Norheim O, Olson Z, Yamey G, Jamison D . Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals. Lancet Glob Health. 2014; 2(12):e698-709. DOI: 10.1016/S2214-109X(14)70316-X. View

13.

Dememew Z, Habte D, Melese M, Hamusse S, Nigussie G, Hiruy N . Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia. Int J Tuberc Lung Dis. 2016; 20(9):1192-8. DOI: 10.5588/ijtld.16.0005. View

14.

Harries A, Hargreaves N, Kemp J, Jindani A, Enarson D, Maher D . Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet. 2001; 357(9267):1519-23. DOI: 10.1016/S0140-6736(00)04639-0. View

15.

Gundersen Storla D, Yimer S, Bjune G . A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008; 8:15. PMC: 2265684. DOI: 10.1186/1471-2458-8-15. View

16.

Adamu A, Gadanya M, Abubakar I, Jibo A, Bello M, Gajida A . High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis. 2017; 17(1):170. PMC: 5324260. DOI: 10.1186/s12879-017-2249-4. View

17.

Dangisso M, Datiko D, Lindtjorn B . Trends of tuberculosis case notification and treatment outcomes in the Sidama Zone, southern Ethiopia: ten-year retrospective trend analysis in urban-rural settings. PLoS One. 2014; 9(12):e114225. PMC: 4252125. DOI: 10.1371/journal.pone.0114225. View

18.

Hanson C, Osberg M, Brown J, Durham G, Chin D . Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods. J Infect Dis. 2017; 216(suppl_7):S679-S685. PMC: 5853893. DOI: 10.1093/infdis/jix387. View

19.

Mberu B, Wamukoya M, Oti S, Kyobutungi C . Trends in Causes of Adult Deaths among the Urban Poor: Evidence from Nairobi Urban Health and Demographic Surveillance System, 2003-2012. J Urban Health. 2015; 92(3):422-45. PMC: 4456477. DOI: 10.1007/s11524-015-9943-6. View

20.

Fine J . Regression modeling of competing crude failure probabilities. Biostatistics. 2003; 2(1):85-97. DOI: 10.1093/biostatistics/2.1.85. View